Sally W. Wade, MPH
Articles
July 23rd 2025
Effects of Adjunctive Cariprazine Formulary Restrictions in Major Depressive Disorder
Nadia Nabulsi, PhD François Laliberté, MA Enrico Zanardo, PhD Sean D. MacKnight, MScPH Sophie Ma, MSc Sally W. Wade, MPH Mousam Parikh, MSc
Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved claims.
July 12th 2018
Two-Year Adherence and Costs for Biologic Therapy for Rheumatoid Arthritis
Bradley S. Stolshek, PharmD Sally W. Wade, MPH Alex Mutebi, PhD, MSc Ajita P. De, MA, MPhil, MS Rolin L. Wade, MS Jason Yeaw, MPH
Adherence to newly initiated biologic therapy for rheumatoid arthritis is important for long-term adherence.
Latest Updated Articles
Published: June 27th 2025 | Updated: July 1st 2025
Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
